Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Glaxo Gets Positive Results From Zejula Study

Mon, 15th Jul 2019 07:40

(Alliance News) - Stock prices in London are seen opening slightly higher on Monday, tracking gains in Chinese equity markets despite a reported slowdown in economic growth there.In early UK company news, pharmaceutical company GlaxoSmithKline reported positive test results for one of its oncology drugs, Mike Ashley's Sports Direct delayed the release of its annual results, and Grainger secured funding for a big development in Leeds. IG futures indicate the FTSE 100 index is to open up 0.63 point at 7,506.60. The blue chip index closed 3.85 points lower, or 0.1%, at 7,505.97 on Friday.Drugmaker AstraZeneca said it has issued a complete response letter to the US Food & Drug Administration regarding the supplemental New Drug Application for diabetes treatment Farxiga. AstraZeneca said it will work with FDA on the next steps for Farxiga.Peer GlaxoSmithKline said it achieved positive results from the Phase 3 study of Zejula, for use for treatment of late-stage ovarian cancer. Glaxo said the study of its niraparib therapy - branded Zejula in the US and Europe - met the primary endpoint and produced statistically significant improvement in progression free survival."Almost 300,000 women around the world are diagnosed with ovarian cancer every year, yet only about 15% of patients are currently eligible to receive pharmacological inhibitors as their initial therapy. These exciting data demonstrate that Zejula has the potential to significantly benefit even more women with this devastating cancer," said Chief Scientific Officer Hal Barron.Sports Direct International said it will delay the release of its annual results, which were originally set for Thursday. The company said the reasons for the delay were due to the "complexities of the integration" of department store chain House of Fraser into the existing business and the current uncertainty regarding the future trading performance of that acquisition. As such, accounting firm Grant Thornton has asked for more time to complete its audit. Sports Direct said there are some "key areas to conclude" which could hurt the guidance given in December. The company now expects its audited results to be published between July 26 and August 23. Separately, Sports Direct said it has secured acceptances for 84% of video game retailer Game Digital's issued share capital. Residential landlord Grainger said it completed forward funding of a 216 home private rented sector development called Fabrik in Leeds for GBP34 million. Grainger said construction of the scheme, which has full planning consent, has recently started with completion expected in late 2021. The company expects the investment to generate a gross yield on cost of over 6.5% once stabilised. In China, the Shanghai Composite is up 0.4%, while the Hang Seng index in Hong Kong is up 0.1%. Financial markets in Japan are closed for the Marine Day public holiday.China's economy grew 6.2% in the second quarter of the year, the slowest pace since the government began publishing the data, in 1992.Economic growth slowed from 6.4% in the first three months of the year, the National Bureau of Statistics said Monday.The rate is still within the growth target set by the government for this year, of at least 6% growth, but it shows how the world's second-largest economy is being stymied by its trade war with the US. The sluggish manufacturing sector is largely responsible for the economic slowdown, with housing and consumption remaining resilient, experts say.In the US on Friday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.9%, S&P 500 up 0.5% and Nasdaq Composite up 0.6%.All three of Wall Street's main indices hit fresh record highs on Friday, ending the week on a strong note as investors grew increasingly confident the Federal Reserve will cut US interest rates at the end of the month. The S&P 500 closed above the 3,000-mark for the first time ever.The pound was quoted at USD1.2566 early Monday, firm against USD1.2554 at the London equities close Friday.Tory leadership contenders Boris Johnson and Jeremy Hunt will go head to head for what is expected to be the final time as the race for No 10 enters its closing stages.The two men will take part in a debate, hosted by The Sun and talkRadio, in front of a live studio audience in London on Monday in what could be the last chance to change the course of the battle to succeed Theresa May.Johnson remains the clear favourite to enter Downing Street on July 24 but supporters of Hunt believe that he is gaining ground.It had been thought that most of the ballot papers from the party's 180,000 grassroots members would have been returned by this stage of the contest.However reports suggest the votes have been coming in more slowly than expected, suggesting many members have been keen to see how the two candidates perform in the campaign before making up their minds.There are no major events remaining in the economic calendar on Monday after the release of the Chinese data.

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.